Track recent robotics regulatory activity, certifications, approvals, standards, and policy signals. Browse dated, source-backed robotics company events with.
Verified Events Sorted by event date, newest first.
Browse the company directory for individual company profiles and the events recorded against each one.
2026-10-21 · regulatory · T-Robotics Industrial
Evidence notes The technology applies precision-control and vacuum-transfer experience developed for 8.6-generation OLED substrate-handling robots. The company is also pursuing related patent applications in China and Taiwan. The development supports planned entry into semiconductor glass-substrate handling and advanced packaging. Date 2026-10-21
Event type Regulatory
Segment Industrial
Added to Korthos 2026-10-21
2026-10-19 Regulatory Intel AI Compute 2026-10-19 · regulatory · Intel AI Compute
Evidence notes The October 16 petition seeks relief under Sections 2.932 and 2.1043 in ET Docket 26-256. Intel says the vehicles have served its fabs for over two decades and that replacing them with qualified alternatives would take years. The named vehicles and suppliers are confined to a confidential appendix; this filing requests permission and does not grant it. Date 2026-10-19
Event type Regulatory
Segment AI Compute
Added to Korthos 2026-10-20
2026-10-16 Regulatory Youibot Industrial 2026-10-16 · regulatory · Youibot Industrial
Evidence notes The company develops industrial logistics and inspection-maintenance systems for sectors including semiconductors, energy and electronics. Its 2025 revenue was approximately RMB340 million, up 33.3%, with industrial logistics contributing 59.4%. Proposed use of IPO proceeds includes embodied-intelligence R&D, facilities, overseas expansion and strategic investment. Date 2026-10-16
Event type Regulatory
Segment Industrial
Added to Korthos 2026-10-18
2026-10-13 · regulatory · Agility Robotics Humanoid
Evidence notes SEC effectiveness is a registration milestone; the business combination remains subject to shareholder approval and other closing conditions. Churchill XI’s extraordinary general meeting is scheduled for 2 November 2026. Agility expects to trade under AGLT following closing; more than $620 million in expected gross proceeds remains conditional. Date 2026-10-13
Event type Regulatory
Segment Humanoid
Added to Korthos 2026-10-14
2026-10-13 Regulatory MAUM.AI Foundation Models 2026-10-13 · regulatory · MAUM.AI Foundation Models
Evidence notes Planned trials cover riverside paths and parks, including stairs, slopes and areas outside fixed CCTV coverage. The proposed system analyses hazards with AI, broadcasts evacuation guidance and relays location and video to a control centre. Date 2026-10-13
Event type Regulatory
Segment Foundation Models
Added to Korthos 2026-10-13
2026-10-13 Regulatory Robros Humanoid 2026-10-13 · regulatory · Robros Humanoid
Evidence notes Named trial hosts are Nepes, Sungwoo Hitech, HD Hyundai Samho and DeliveryLab. Tasks include semiconductor-part cleaning, car-body component placement, scaffolding-piece handling and refrigerated package loading. The exemption enables mobile humanoid work under supplemented safety conditions where rules had assumed fixed industrial robots. Date 2026-10-13
Event type Regulatory
Segment Humanoid
Added to Korthos 2026-10-13
2026-10-12 Regulatory Tesla Automotive 2026-10-12 · regulatory · Tesla Automotive
Evidence notes The petition was received September 23 and concerns Model Y and Cybercab vehicles with the Automated Driving System engaged. The opening resume estimates 1,000 vehicles and lists four reports, with no crashes, injuries or fatalities recorded. The agency will decide whether to grant or deny the petition; this opening is not a defect finding or recall. Date 2026-10-12
Event type Regulatory
Segment Automotive
Added to Korthos 2026-10-12
2026-10-08 Regulatory XCath Surgical 2026-10-08 · regulatory · XCath Iris Endovascular Robotic System Surgical
Evidence notes Enrollment follows Iris’s September 2, 2026 Breakthrough Device designation. A dedicated FDA advisor and review-team engagement will cover development decisions, with facilitated input from payers, providers and other stakeholders. Iris remains under development and is not cleared for commercial distribution in any country. Date 2026-10-08
Event type Regulatory
Segment Surgical
Added to Korthos 2026-10-08